{"name":"Ziarco Pharma Ltd","slug":"ziarco-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxObnhRbERRcGJvNmFxa3ZKSGRNYnMyYTQ0Z3NNaWtGMTh6Qm5OMFhjNnA1YnU2SDFacnZHeUZtWlNRX1FLSG94alIyOVF5OFpqcWlNX1pmblFpdE1RRkhyREgtLVdJV05TS3hHZ3ZvUUJvU0RnTFN4TVhTdzZPZE9lcDNMc1habHotVzJDS3pydzd1dWQ4cVE?oc=5","date":"2020-07-22","type":"regulatory","source":"pharmaphorum","summary":"Novartis takes $485m hit after axing eczema drug from pipeline - pharmaphorum","headline":"Novartis takes $485m hit after axing eczema drug from pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQMkpRbk5YeXphcXFhcnBSd3FYX1RCNXFCN3MydXNIT0hTcW4ydlRDVWNrQlRBd0pHekR1ek1Da0tHSk1obksyQjdiRGZ3SC1UaGRhd2Y1b040X2l6bjNWR2Y4NzdGMnQ0RTJ3cENhQ1IzdE1kTEVHeEY1cV80WkNUUWs3aHpQQ29BVGNfODhCdmk?oc=5","date":"2020-07-21","type":"regulatory","source":"Fierce Biotech","summary":"Novartis dumps Ziarco eczema drug, taking $485M hit - Fierce Biotech","headline":"Novartis dumps Ziarco eczema drug, taking $485M hit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMFpnbnB2N1lLQWhpLUtMMHE0dWw3eHdiRl9IWVkzUzNwV3JfUjJabU81NEJHU1pKeG13aHZaZEE1bzZ4ZW50ZDNFUGg4SHAyUnFXQzNSSWJmWk51RmZ1S2ZOSi1CaW1kVjFYMGlCd3JmNDhRNjkySzlHRUpWaldfUVkxZWZ2YWthcFpJTk96NE8td0xpUDdoVG5wOE8yLWJjelFmZXhmUk5wNURVeGpMU3RYT19LUGNIczFtR1V4ZkRLbkNfSW50c0cxNnR1SmxvZ2c?oc=5","date":"2019-07-08","type":"pipeline","source":"Novartis","summary":"Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited - Novartis","headline":"Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMlJwZFpHaS0wdVNfV1Ftd0p0eGdkMXNTNW9PYm5WR1p1V2c5eW9STFRHNjZQMGpTVnFpQTFVeW5FbGhadjJGVTRoR1k0NjRuQnZ2SnV1c3k2bWF3SXNUc0s1SWJIZEZXN241akR1bUZSaDlMTWRQcFVNc1UxNHk0eS1RYjExeFZhMUs2cTVzVDBGWjg?oc=5","date":"2016-12-16","type":"pipeline","source":"pharmaphorum","summary":"Success for ex-Pfizer scientists with Novartis dermatology sale - pharmaphorum","headline":"Success for ex-Pfizer scientists with Novartis dermatology sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNd0w1cTV6MXlLMEI3UmhkYm0wNEFHNzdVNmw4Q2pQV3hFaUF0QUtDSC1kcTNIS2FLYzVJeFE2emNFN1VQWGdlbUxCY2lVbEp0cUdhdFhJRldJRVlYbC00TXBzc3dWVWlHNnZucFRKWjc0czhlb1EtVFRZcmY5MWg1SkZPV0lvYzZ2NG9Palln?oc=5","date":"2016-12-16","type":"deal","source":"Fierce Biotech","summary":"Novartis boosts dermatology pipeline with Ziarco buy - Fierce Biotech","headline":"Novartis boosts dermatology pipeline with Ziarco buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQeXZ2X01lQW5mMVh5cGc5R0s0TmFKNUhPR1dqX1JTb2E2dkpEc3J0LWVNY1VuYVFfMUI0aFhHMEhJdEw1Nzhrc3ZNVzRVbGhSbDdySzI2UXBfcjVRVTZiVFhiVU95d2xkNW5DdWFUeTZ2NFBlQnJtNjlaMU5EWDlHWUNjZTI?oc=5","date":"2013-03-20","type":"pipeline","source":"Pharmafile","summary":"Ziarco appoints John LaMattina as R&D advisor - Pharmafile","headline":"Ziarco appoints John LaMattina as R&D advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNY0hWOWZfT081TTZiU082NjB4dGk5eDUwLTNYeEpSTy1rZFFIQmRpVTBMcGR6NGV2M184bFlGU1pnOVVTQlFxV1hxSFNPVmxPQjROeWpobTdZU09PaF9IbnBkMnRRTVNPM1V2MzRPeXZHeFZpX195OE9MN0d4YWc5R0RxenJhamJrbHNVSWI4LW5jVGtta1pSSHUzVXJsdGhMNk5FcUc1NEowNFpaM2NaMDFyVnJseFNHRmRMSQ?oc=5","date":"2012-11-05","type":"pipeline","source":"PMLiVE","summary":"Pfizer helps fund biotech venture from former researchers at closed Kent facility - PMLiVE","headline":"Pfizer helps fund biotech venture from former researchers at closed Kent facility","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}